FSM Wealth Advisors LLC Acquires Shares of 3,039 Cigna Group $CI

Key Points

• FSM Wealth Advisors LLC acquired 3,039 shares of Cigna Group, a stake worth approximately $953,000, during the second quarter.
• Cigna reported earnings of $7.20 per share for the last quarter, exceeding analysts' estimates of $7.15, with revenue of $67.13 billion.
• The company announced a quarterly dividend of $1.51 per share set to be paid on December 18th, representing a 2.0% yield.

FSM Wealth Advisors LLC acquired a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,039 shares of the health services provider's stock, valued at approximately $953,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Flaharty Asset Management LLC acquired a new stake in Cigna Group during the first quarter valued at approximately $28,000. 1248 Management LLC acquired a new stake in Cigna Group during the first quarter valued at approximately $29,000. Activest Wealth Management raised its stake in Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after buying an additional 72 shares in the last quarter. Princeton Global Asset Management LLC raised its stake in Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider's stock valued at $32,000 after buying an additional 52 shares in the last quarter. Finally, Retirement Wealth Solutions LLC raised its position in shares of Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock worth $33,000 after purchasing an additional 43 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $303.90 on Thursday. The firm has a market cap of $81.12 billion, a price-to-earnings ratio of 16.60, a P/E/G ratio of 0.90 and a beta of 0.45. Cigna Group has a 1 year low of $256.89 and a 1 year high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The business has a fifty day simple moving average of $298.83 and a 200 day simple moving average of $307.81.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business's revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the firm earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group's dividend payout ratio (DPR) is 32.97%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Cantor Fitzgerald reiterated an "overweight" rating and set a $365.00 price target on shares of Cigna Group in a research report on Tuesday, August 26th. Robert W. Baird set a $372.00 price target on Cigna Group in a research note on Thursday, August 14th. Guggenheim reissued a "buy" rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of "Moderate Buy" and an average target price of $369.89.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.